Bone marrow involvement is a risk factor for infusion-related reactions in patients with follicular lymphoma treated by obinutuzumab

被引：0
|
作者：
Yosuke Masamoto
Kazuki Taoka
Hiroaki Maki
Mineo Kurokawa
机构：
[1] The University of Tokyo,Department of Hematology and Oncology, Graduate School of Medicine
[2] The University of Tokyo Hospital,Department of Cell Therapy and Transplantation Medicine
来源：
Annals of Hematology | 2022年 / 101卷
关键词：
Follicular lymphoma; Obinutuzumab; Infusion-related reactions; Risk factors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2795 / 2797
页数：2
相关论文
共 50 条
  • [1] Bone marrow involvement is a risk factor for infusion-related reactions in patients with follicular lymphoma treated by obinutuzumab
    Masamoto, Yosuke
    Taoka, Kazuki
    Maki, Hiroaki
    Kurokawa, Mineo
    ANNALS OF HEMATOLOGY, 2022, 101 (12) : 2795 - 2797
  • [2] Safe administration of rituximab for follicular lymphoma after obinutuzumab infusion-related reaction
    Hara, Takeshi
    Suzuki, Ryohei
    Ohno, Akihisa
    Yamakawa, Kengo
    Yamagishi, Yasumasa
    Sugiyama, Yoshihiro
    Sobajima, Takuya
    Yamada, Rie
    Matsumoto, Rie
    Ikeda, Yoko
    Murayama, Masanori
    Tsurumi, Hisashi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 111 (04) : 585 - 590
  • [3] Safe administration of rituximab for follicular lymphoma after obinutuzumab infusion-related reaction
    Takeshi Hara
    Ryohei Suzuki
    Akihisa Ohno
    Kengo Yamakawa
    Yasumasa Yamagishi
    Yoshihiro Sugiyama
    Takuya Sobajima
    Rie Yamada
    Rie Matsumoto
    Yoko Ikeda
    Masanori Murayama
    Hisashi Tsurumi
    International Journal of Hematology, 2020, 111 : 585 - 590
  • [4] Cytokine release in patients with CLL treated with obinutuzumab and possible relationship with infusion-related reactions
    Freeman, Ciara L.
    Morschhauser, Franck
    Sehn, Laurie
    Dixon, Mark
    Houghton, Richard
    Lamy, Thierry
    Fingerle-Rowson, Guenter
    Wassner-Fritsch, Elisabeth
    Gribben, John G.
    Hallek, Michael
    Salles, Gilles
    Cartron, Guillaume
    BLOOD, 2015, 126 (24) : 2646 - 2649
  • [5] Bone marrow involvement is predictive of infusion-related reaction during rituximab administration in patients with B cell lymphoma
    Junshik Hong
    Ji Yeon Kim
    Hee Kyung Ahn
    Sang-Min Lee
    Sun Jin Sym
    Jinny Park
    Eun Kyung Cho
    Jeong Yeal Ahn
    Sanghui Park
    Sang Pyo Lee
    Dong Bok Shin
    Jae Hoon Lee
    Supportive Care in Cancer, 2013, 21 : 1145 - 1152
  • [6] Bone marrow involvement is predictive of infusion-related reaction during rituximab administration in patients with B cell lymphoma
    Hong, Junshik
    Kim, Ji Yeon
    Ahn, Hee Kyung
    Lee, Sang-Min
    Sym, Sun Jin
    Park, Jinny
    Cho, Eun Kyung
    Ahn, Jeong Yeal
    Park, Sanghui
    Lee, Sang Pyo
    Shin, Dong Bok
    Lee, Jae Hoon
    SUPPORTIVE CARE IN CANCER, 2013, 21 (04) : 1145 - 1152
  • [7] Managing Infusion-Related Reactions for Patients With Chronic Lymphocytic Leukemia Receiving Obinutuzumab
    Dawson, Keith
    Moran, Mollie
    Guindon, Kathleen
    Wan, Hui
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2016, 20 (02) : E41 - E48
  • [8] Assessment of Measures to Reduce Infusion-Related Reactions in Patients with Chronic Lymphocytic Leukemia Treated with Obinutuzumab in the GREEN Study
    Bosch, Francesc
    Foa, Robin
    Cortelezzi, Agostino
    Kisro, Jens
    Leblond, Veronique
    Tumyan, Gayane
    Gresko, Ekaterina
    Robson, Susan
    Stilgenbauer, Stephan
    BLOOD, 2016, 128 (22)
  • [9] Follicular pattern of bone marrow involvement by follicular lymphoma
    Torlakovic, E
    Torlakovic, G
    Brunning, RD
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2002, 118 (05) : 780 - 786
  • [10] Role of CD20 expression and other pre-treatment risk factors in the development of infusion-related reactions in patients with CLL treated with obinutuzumab
    Freeman, C. L.
    Dixon, M.
    Houghton, R.
    Kreuzer, K-A
    Fingerle-Rowson, G.
    Herling, M.
    Humphrey, K.
    Boettcher, S.
    de Costa, C. S.
    Iglesias, V.
    Stilgenbauer, S.
    Gribben, J.
    Hallek, M.
    Goede, V.
    LEUKEMIA, 2016, 30 (08) : 1763 - 1766
12345